Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]

Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatr Dis Treat. 2016;12:763–775. The Editor-in-chief and Publisher of Neuropsychiatric Disease and Treatment wish to retract the published article. Following the conclusion of our investigation the decis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hinz M, Stein A, Cole T, McDougall B, Westaway M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
b6
Acceso en línea:https://doaj.org/article/dda3b69deac94da79d944cab1ed9d248
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dda3b69deac94da79d944cab1ed9d248
record_format dspace
spelling oai:doaj.org-article:dda3b69deac94da79d944cab1ed9d2482021-12-02T12:53:55ZParkinson’s Disease Managing Reversible Neurodegeneration [Retraction]1178-2021https://doaj.org/article/dda3b69deac94da79d944cab1ed9d2482020-12-01T00:00:00Zhttps://www.dovepress.com/retraction-parkinsonrsquos-disease-managing-reversible-neurod-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatr Dis Treat. 2016;12:763–775. The Editor-in-chief and Publisher of Neuropsychiatric Disease and Treatment wish to retract the published article. Following the conclusion of our investigation the decision has been made to retract the published article. The authors did not provide the requested IRB and informed consent information relating to this study and it was determined the study did not meet the ethical publication requirements for research involving human subjects. These requirements are based on guidelines issued by the World Medical Association and the International Committee of Medical Journal Editors. Additionally, the authors did not provide the study protocols, raw data and other study documents relating to this study as requested. Given our concerns about the standard of research ethics, competing interests and that the authors have not supplied the information we requested to verify and validate the reported findings, the editor has determined the article should be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paperHinz MStein ACole TMcDougall BWestaway MDove Medical Pressarticleparkinson’s diseasel-dopacarbidopab6neurodegenerationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 3125-3126 (2020)
institution DOAJ
collection DOAJ
language EN
topic parkinson’s disease
l-dopa
carbidopa
b6
neurodegeneration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle parkinson’s disease
l-dopa
carbidopa
b6
neurodegeneration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Hinz M
Stein A
Cole T
McDougall B
Westaway M
Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
description Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatr Dis Treat. 2016;12:763–775. The Editor-in-chief and Publisher of Neuropsychiatric Disease and Treatment wish to retract the published article. Following the conclusion of our investigation the decision has been made to retract the published article. The authors did not provide the requested IRB and informed consent information relating to this study and it was determined the study did not meet the ethical publication requirements for research involving human subjects. These requirements are based on guidelines issued by the World Medical Association and the International Committee of Medical Journal Editors. Additionally, the authors did not provide the study protocols, raw data and other study documents relating to this study as requested. Given our concerns about the standard of research ethics, competing interests and that the authors have not supplied the information we requested to verify and validate the reported findings, the editor has determined the article should be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
format article
author Hinz M
Stein A
Cole T
McDougall B
Westaway M
author_facet Hinz M
Stein A
Cole T
McDougall B
Westaway M
author_sort Hinz M
title Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
title_short Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
title_full Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
title_fullStr Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
title_full_unstemmed Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
title_sort parkinson’s disease managing reversible neurodegeneration [retraction]
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/dda3b69deac94da79d944cab1ed9d248
work_keys_str_mv AT hinzm parkinsonrsquosdiseasemanagingreversibleneurodegenerationretraction
AT steina parkinsonrsquosdiseasemanagingreversibleneurodegenerationretraction
AT colet parkinsonrsquosdiseasemanagingreversibleneurodegenerationretraction
AT mcdougallb parkinsonrsquosdiseasemanagingreversibleneurodegenerationretraction
AT westawaym parkinsonrsquosdiseasemanagingreversibleneurodegenerationretraction
_version_ 1718393596328017920